Glycosan BioSystems Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Glycosan BioSystems General Information

Description

Manufacturer of formulations of a hyaluronan-based synthetic extracellular matrix. The company offers Extracel and HyStem for stem cell researchers, Extracel-HP and HyStem-HP for applications which require slow release of growth factors in a cell's microenvironment and Extracel-X for growing tumor xenografts in mice.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
OrthoCyte Corp.
Primary Office
  • 675 Arapeen Drive
  • Suite 302
  • Salt Lake City, UT 84108
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycosan BioSystems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Glycosan BioSystems‘s full profile, request access.

Request a free trial